Johnson & Johnson (NYSE:JNJ) might seem like the dud of the Dividend Aristocrats so far this year, with the stock down about 7% and fourth-quarter sales giving investors a little pause. But if you dig a little deeper into its business and Q4 report, you’ll find that JNJ is actually a diamond in the rough. JNJ disappointed some investors after it reported that Q4 sales were down 0.6% year-over-year. But Johnson & Johnson did beat the consensus estimate for earnings per share by 1 cent, and profits overall were up 2.5% from the year-ago period.
Before you write JNJ stock off as dead money, consider these three reasons why you should stick with Johnson & Johnson in 2015. 1. JNJ Sales Were Better Than You Think: Although sales for Johnson & Johnson’s Hepatitis C drug Olysio were down, CEO Alex Gorksy expected this to happen. 2. Of Course, There’s the Dividend: JNJ is a Dividend Aristocrat that has increased its payout every year for 52 years, including its most recent increase of 6% to 70 cents quarterly. 3. Promising New Investment: JNJ is making strategic investments that will only make Johnson & Johnson stronger. 4. Johnson & Johnson Reasonably Priced: JNJ currently has a price-to-earnings ratio under 18, making it an undervalued stock compared to its competitors.
Source: InvestorPlace
Related Articles:
- The Perfect Dividend Stock
- Bonds Look Morbid When Compared To These Dividend Stocks
- My 5 Largest Dividend Stock Positions Have Double-Digit Lifetime Returns
- The Best Dividend Stocks In The World
- 12 Dividend Stocks With 50+ Years of Consecutive Increases
________________________________________________________________
Subscribe to:
Post Comments (Atom)
Popular Posts Last 30 Days
-
These days, the healthcare stocks are looking pretty healthy compared to stocks in other spaces. Despite political pressures about lowering ...
-
Nothing makes life easier for an investor than finding the kind of stocks where you can park money for a long, long time, trusting that they...
-
These three dividend aristocrats have beaten the market during the three most recent pullbacks. They've also outperformed in 2019. There...
-
As the sun sinks on another summer and Labor Day taunts with the pitiful proposition of just 24 hours less work, it stands to reason that so...
-
In Five High-Dividend Stocks You Should Watch, we discussed five dividend stocks, including MLPs, trading at yields above 11%. In this artic...
-
The past decade has rewarded investors with remarkable returns, but investors might not want to underestimate the odds that an economic rece...
-
This company recently released solid second quarter earnings. The mortgage REIT once again outearned its dividend with core earnings in Q2-2...
-
This company released Q2-2019 results recently. The results beat both revenue and earnings estimates. It reported decreasing earnings on the...
-
Conservative investors should adopt the same precautions toward monthly dividend stocks as you would any income-generating investment. For i...
-
As a risk-averse income investor, I always approach double-digit yielders with caution. The reason is simple: when most blue-chip companies ...
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.